9WAH image
Deposition Date 2025-08-12
Release Date 2026-03-04
Last Version Date 2026-04-15
Entry Detail
PDB ID:
9WAH
Title:
Yeast-expressed polio type 1 stabilized virus-like particles
Biological Source:
Source Organism(s):
Poliovirus 1 (Taxon ID: 12080)
Expression System(s):
Method Details:
Experimental Method:
Resolution:
2.43 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Capsid protein VP4
Chain IDs:D (auth: F)
Chain Length:69
Number of Molecules:1
Biological Source:Poliovirus 1
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Capsid protein VP2
Chain IDs:C (auth: H)
Chain Length:272
Number of Molecules:1
Biological Source:Poliovirus 1
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Capsid protein VP3
Chain IDs:B (auth: I)
Chain Length:238
Number of Molecules:1
Biological Source:Poliovirus 1
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Capsid protein VP1
Chain IDs:A (auth: J)
Chain Length:302
Number of Molecules:1
Biological Source:Poliovirus 1
Ligand Molecules
Primary Citation
Structural insight into the assembly and D antigenicity of polio type 1 stabilized virus-like particles.
Npj Vaccines 11 ? ? (2026)
PMID: 41735326 DOI: 10.1038/s41541-026-01404-0

Abstact

The inherent instability of poliovirus capsids presents a formidable challenge for developing next-generation vaccines suitable for a post-eradication world. Here, we address this by engineering a thermally stabilized virus-like particle (sVLP) derived from the poliovirus serotype 1 (PV1) Mahoney-SC7 mutant and elucidating its atomic-level structure. Produced at remarkably high yields in Pichia pastoris yeast, our engineered sVLP maintains a native, D-antigenic conformation and elicits a potent neutralizing antibody response in mice, in sharp contrast to unstable wild-type VLP (wtVLP) which adopts an expanded, non-immunogenic form. Our 2.43 A resolution cryo-EM structure reveals precisely how seven stabilizing mutations cooperatively enhance inter-protomer contacts and rigidify surface loops to lock the particle in its immunogenic state. We further define a critical D-antigenic epitope by determining the 2.60 A structure of the sVLP in complex with a novel D-antigen-specific, neutralizing monoclonal antibody, 3G10, elucidating the structural mechanisms of D-antigen recognition and virus neutralization by 3G10. These findings provide a definitive structural blueprint for engineering stable, immunogenic vaccines for PVs and other enteroviruses and also deliver a vital reagent for ensuring vaccine quality control.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback